LGND is up +7.88% in the last 5 days.
As of 03/13/15 LGND is at 74.99 +2.79 +3.86%
Ligand Pharmaceuticals Inc (LGND)
http://investorshangout.com/Ligand-Pharmaceut...GND-54621/
Taking Shots at New Mexico's Gun Laws You've got the National Shooting Sports Foundation (NSSF) heading back into the legal trenches. Fresh lawsuit filed, they're targeting New Mexico's Attorney General, Raúl Torrez, for trying to keep a seven-day "cooling off" period intact that they've already been told is unconstitutional. Look, this ain't their first rodeo with this...
Continue Reading
GPU Utilization Gets a New Spin with Flex VMs Folks, listen up: Shadeform just fired up something slick with its new Flex VMs. And, let me tell you, in today's market where GPU capacity is vanishing faster than free hotcakes on a Sunday morning, this might well be a game changer. Shadeform’s the name to remember, teaming up data center veterans with peeps who need to...
Continue Reading
Burger King's Hello Kitty® Move: Fad or Brilliant? Few things scream nostalgia like Hello Kitty® and a Burger King kids' meal. It's the kind of combo that makes you wonder if we're simply riding a wave of kawaii nostalgia or if this is a masterstroke tapping into a multi-generational goldmine. What's in the Box? Burger King isn't playing around. Starting October 20,...
Continue Reading
Legal Spotlight on Hughes Brothers Construction Inc. Talk about a shakeup. Hughes Brothers Construction Inc. finds itself under the sharp scrutiny of a class action magnifying glass. We're not talking some small-time whispers either; Monteverde & Associates is the name here—top dogs in the securities class action world. This crew's headquartered in the iconic Empire...
Continue Reading
Unanticipated Software Costs: Who's in Charge? Picture this: you're running a tech setup at a major corporation, but the software changes thrust upon you aren't anything you would've chosen freely. Yeah, that's about one in four dollars from your hot little budget spent on tweaks and adjustments you didn’t ask for. And it's not as glamorous as it sounds—more like a...
Continue Reading
Ecopetrol: A Rock in Turbulent Waters If you’re looking for a boulder in a sea of pebbles, Ecopetrol’s got the heft. When Fitch Ratings gives a thumbs-up, you best believe they mean it. On October 20, 2026, the rating agency confirmed Ecopetrol’s global credit rating at BB, with a stable outlook, but it’s how they got there that counts. Their standalone credit...
Continue Reading
Celebrating Impact Through Parenthood Narratives Blending heartfelt stories with educational insights, the Parents as Teachers Podcast stands tall as a Finalist in two categories of the 6th Annual Anthem Awards. Recognizing achievements in Content & Media for both Education, Art & Culture and Health, this nod acknowledges the profound impact being made on family...
Continue Reading
Eco-Friendly Floors or Marketing Fluff? On the surface, Ecore Athletic inking a deal with the American Conference seems like another run-of-the-mill partnership. But dig a little deeper, and it’s not just hardwood and rubber underfoot. There’s some serious ambition here, along with a dash of circularity PR. A Partnership with Broader Impact The nitty-gritty of the...
Continue Reading
Setting Sail with Norwegian Bella™ in 2028 When you hear about another cruise ship hitting the water, eye rolls might come naturally. But Norwegian Cruise Line's latest announcement adds a few twists worth noting. Today, the big news is that the Norwegian Bella™, the freshest face in NCL's innovative Prima Class, is now open for bookings. This beauty will start its...
Continue Reading
Shadeform's Spot Aims To Cut GPU Waste Imagine letting money burn while your GPUs sit in idle mode. That's the reality for many in the cloud computing sector, and Shadeform looks ready to tackle this inefficiency head-on. The launch of Spot, by the GPU Cloud Marketplace Shadeform, offers a novel way to make sure every floating gigaflop translates into some form of...
Continue Reading
Editas Medicine's Upcoming Presentation Highlights Editas Medicine, Inc. (NASDAQ: EDIT), a trailblazer in gene editing, is excited to announce that it will present at the renowned European Society of Gene and Cell Therapy (ESGCT) Congress. The congress is set to occur from October 7 to October 10, making this a significant occasion for the company and the field of gene...
Continue Reading
ICP DAS-BMP Showcases Medical Innovations at COMPAMED ICP DAS-BMP, a prominent manufacturer from Taiwan, is gearing up for the prestigious COMPAMED event taking place in Germany. This event, which draws significant attention from the medical device industry, showcases advancements in medical-grade thermoplastic polyurethane (TPU) materials. Focus on Low-Migration and...
Continue Reading
Broadcom's Recent Performance and Growth Potential Broadcom Inc. has made headlines recently with its remarkable performance in the tech sector. Following a solid earnings report for the second quarter, this semiconductor leader has seen its stock, designated as AVGO, score a notable jump of nearly 19% year-to-date. This surge has been particularly impressive, as the...
Continue Reading
InCarda Therapeutics Welcomes Dr. Myles Greenberg as CEO InCarda Therapeutics, a clinical-stage biopharmaceutical firm dedicated to developing cutting-edge treatments for cardiac arrhythmias, has appointed Dr. Myles Greenberg, MD, MBA, as its new Chief Executive Officer. Dr. Greenberg is set to lead the company as they work on their flagship product, an orally inhaled...
Continue Reading
Understanding Jim Cramer's Perspective on Nvidia CNBC’s Jim Cramer hinted at a potential turning point for NVIDIA Corp. (NASDAQ: NVDA) after the stock reached $127. This could signal a bottom for the semiconductor giant after its recent setbacks. Market Dynamics: What Cramer Noted Cramer’s Observations According to Cramer, the $127 mark could indicate a pivotal moment...
Continue Reading